prof Aleksander P. Mazurek

Affiliation:

Medical University of Warsaw, Department of Drug Chemistry

Affiliation:

Narodowy Instytut Lekow

Participant:

V Multidyscyplinarna Konferencja Nauki o Leku

Participant:

VI Multidyscyplinarna Konferencja Nauki o Leku

Participant:

VII Multidyscyplinarna Konferencja Nauki o Leku

Participant:

IX Multidyscyplinarna Konferencja Nauki o Leku

Publications:

1. Alkyl-nitroquipazine derivatives as serotonin transporter and 5-HT_1A receptor ligands
2. Application of amylose tris(3,5dimethylphenyl- carbamate) chiral stationary phase for the determination of paroxetine, clinically used psychotropic drug
3. Application of carbohydrate based chiral stationary phase for resolution of  fenoterol, clinically used chiral drug
4. Application of silica-bonded ovomucoin protein chiral stationary phase for the determination of paroxetine, clinically used psychotropic drug
5. Comparison of properties of cyclic and linear glycine derived structures and their phosphorus analogues - theoretical studies
6. Cyclohexaglycine as a potential ionophore
7. DETERMINATION OF SELECTED MEDICINES REDUCING THE LEVEL OF CHOLESTEROL BY CHROMATOGRAPHIC METHODS.
8. Determination of the enantiomeric purity of epinephrine in pharmaceutical preparations
9. Determination of the enantiomeric purity of norepinephrine in pharmaceutical preparations
10. Direct enantiomeric resolution of tamsulosin, clinically used chiral O-phenylethanolamine derivative with α₁-blocking activity
11. Examination of optical isomerism - compounds of antihypertensive effects.
12. Fullerenes as the carriers of compounds with amide bond
13. IDENTIFICATION AND DETERMINATION OF ANGIOTENSIN II RECEPTOR ANTAGONISTS WITH DENSITOMETRIC METHOD
14. MOLECULAR DETERMINANTS FOR METABOLIC STABILITY OF NICOTINIC AND PICOLINIC ACID DERIVATIVES
15. Molecular properties impact on bioavailability of imidazole antifungal agents.
16. Molecular properties of active ingredients Impact on bioavailability The biopharmaceutics classification system
17. Molecular properties of antifungal agents – Impact on bioavailability – The Biopharmaceutics Classification System
18. MOLECULAR PROPERTIES OF SULCONAZOLE AND ECONAZOLE RELEVANT TO BIOAVAILABILITY
19. Molecular Properties Relevant to Bioavailability of Tioconazole  and its Derivatives
20. On tautomerism of the pyridodiazepines. A DFT study.
21. The ligand binding to the serotonin transporter